Navigation Links
Investor Call Scheduled to Discuss Ouster Proposal of Trinity Biotech Directors
Date:10/27/2008

KANSAS CITY, Mo., Oct. 27 /PRNewswire/ -- Thomas Reidy, an investor in Trinity Biotech plc (Nasdaq: TRIB), an Ireland-based developer and manufacturer of diagnostic products whose American Depository Receipts are traded on NASDAQ, will host an investor conference call November 3, 2008, at 10:00am EST, to discuss the recent shareholder proposal calling for the removal and replacement of Trinity Biotech's current directors.

On October 16, 2008, Mr. Reidy, and nine other shareholders, sent a letter to Trinity Biotech requesting that a special meeting of shareholders be held to consider the immediate removal of the current directors of Trinity Biotech. In the same letter, the investor group, who collectively hold beneficial ownership of more than 10% of Trinity Biotech's voting stock, directed that Trinity Biotech shareholders be given the opportunity to vote on the following slate of replacement directors:

-- Dr. Jack C. Chow, M.D., M.B.A. -- Partner, CRV Capital, LLC and adjunct

professor at Carnegie Mellon University's Heinz School of Public Policy

and Management;

-- Mr. Mike Gausling -- Managing Partner, Originate Ventures;

-- Dr. John H. Halsey, Ph.D. -- Chief Executive Officer, Director,

Founder, ProGene Biomedical, Inc. (dba IBT Laboratories);

-- Mr. Steven A. Mock, CPA -- Partner, BKD, LLP;

-- Mr. Thomas Reidy; and

-- Mr. Clint Severson -- Chairman, President and CEO of Abaxis, Inc.

According to Irish Law, Trinity Biotech must call a special meeting of shareholders, called an Extraordinary General Meeting, if the meeting is requested by shareholders holding in excess of 10% of the voting paid-up capital of the company.

The purpose of the conference call will be to provide Trinity Biotech shareholders information regarding the reasons for the proposal, the company's response to the proposal, if any, the qualifications of the replacement directors, and steps that shareholders can take to impose accountability on company management.

The conference call can be accessed in the U.S. by dialing 1-800-899-9949 conference code 2111155.

Thomas J. Reidy, Kansas City, (816) 260-8476


'/>"/>
SOURCE Thomas J. Reidy, Kansas City
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nile Therapeutics to Present at the 7th Annual BIO Investor Forum
2. GenVault to Present at the BIOCOM Investor Conference
3. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
4. China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
5. BioAtom Inc. To Present at BIOCOM Investor Conference 2008
6. Gerson Lehrman Group and BIO Collaborate to Identify Scientific Expertise for the Seventh Annual BIO Investor Forum
7. Oncothyreon to present at BIO Investor Forum 2008
8. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
9. Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum
10. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
11. WaferGen to Present at the Seventh Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 7, 2016  Genprex, Inc. a biopharmaceutical company ... treatments, today announced that it has retained ICR ... strategic communications and advisory firm, to develop and ... will combine investor relations, public relations and digital ... profile of Genprex and its lead candidate Oncoprex, ...
(Date:12/7/2016)... DIEGO , December 7, 2016 ... in the International Journal of Molecular Sciences a team of ... 1 ] have demonstrated that expression of NR2F6 ...  These scientists tested for NR2F6 in patient,s cervical cancer tissue ... their tumors. "This is an interesting study and ...
(Date:12/7/2016)... ... December 07, 2016 , ... JULABO USA is ... cart. The new website has been designed to provide the best user-friendly experience ... to access detailed product information, read educational industry content as well as share ...
(Date:12/6/2016)... , Dec. 6, 2016 The American Botanical ... adoption of arnica ( Arnica montana ) through ... ABC,s HerbMedPro database, a comprehensive, interactive ... and clinical research data on the uses and ... Naturopathica, a wellness company with healing ...
Breaking Biology Technology:
(Date:12/5/2016)... Dec. 5, 2016  The Office of Justice ... "Can CT Scans Enhance or Replace Medico Legal ... of supporting or replacing forensic autopsies with postmortem ... In response to recommendations made by ... using CT scans as a potential component of ...
(Date:11/30/2016)...  higi SH llc (higi) announced today the ... brands, industry thought-leaders and celebrity influencers looking to ... taking steps to live healthier, more active lives. ... has built the largest self-screening health station network ... who have conducted over 185 million biometric screenings.  ...
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
Breaking Biology News(10 mins):